| Trial ID: | L7304 |
| Source ID: | NCT00308451
|
| Associated Drug: |
Chromium Picolinate (600 Mcg Cr+3) + Biotin (2 Mg)
|
| Title: |
A 30 Day Acute Efficacy and Safety Study of Chromium Picolinate + Biotin on Glycemic Control in Overweight or Obese Subjects With T2DM
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Chromium Picolinate (600 mcg Cr+3) + biotin (2 mg)
|
| Outcome Measures: |
Primary: Primary(baseline versus final): AUCg as recorded from a 2-hour OGTT with 75 g glucose beverage; fructosamine; fasting plasma glucose. | Secondary: Secondary (baseline versus final): Lipid panels (Total-C, HDL, LDL, VLDL), lipid ratios , apolipoprotein A and B.
|
| Sponsor/Collaborators: |
Sponsor: Nutrition 21, Inc.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
40
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2003-11
|
| Completion Date: |
2004-04
|
| Results First Posted: |
|
| Last Update Posted: |
2006-03-29
|
| Locations: |
Radiant Research Chicago, Chicago, Illinois, 60610, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00308451
|
